Two key proteins perform powerful functions on a major secretory pathway
RyboDyn joins Lilly Gateway Labs to advance next-gen immunotherapies
Study reveals processes important for skin cancer aggressiveness and identifies two classes of drugs that may block them
FDA Fast Track Designation for gel to treat calciphylaxis ulcers